Your browser doesn't support javascript.
loading
Transfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance factor.
Goujon, Caroline; Moncorgé, Olivier; Bauby, Hélène; Doyle, Tomas; Barclay, Wendy S; Malim, Michael H.
Afiliação
  • Goujon C; Department of Infectious Diseases, King's College London, London, United Kingdom caroline.goujon@kcl.ac.uk michael.malim@kcl.ac.uk.
  • Moncorgé O; Section of Virology, Department of Medicine, Imperial College London, London, United Kingdom.
  • Bauby H; Department of Infectious Diseases, King's College London, London, United Kingdom.
  • Doyle T; Department of Infectious Diseases, King's College London, London, United Kingdom.
  • Barclay WS; Section of Virology, Department of Medicine, Imperial College London, London, United Kingdom.
  • Malim MH; Department of Infectious Diseases, King's College London, London, United Kingdom caroline.goujon@kcl.ac.uk michael.malim@kcl.ac.uk.
J Virol ; 88(16): 9017-26, 2014 Aug.
Article em En | MEDLINE | ID: mdl-24899177
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Fatores R / HIV-1 / Proteínas de Resistência a Myxovirus / Membrana Nuclear Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Virol Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Fatores R / HIV-1 / Proteínas de Resistência a Myxovirus / Membrana Nuclear Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Virol Ano de publicação: 2014 Tipo de documento: Article